UniSuper Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $214K | Sell |
1,700
-200
| -11% | -$25.1K | ﹤0.01% | 675 |
|
|
2025
Q1 | $210K | Hold |
1,900
| – | – | ﹤0.01% | 688 |
|
|
2024
Q4 | $259K | Sell |
1,900
-6,102
| -76% | -$833K | ﹤0.01% | 666 |
|
|
2024
Q3 | $922K | Buy |
8,002
+1,070
| +15% | +$123K | 0.01% | 576 |
|
|
2024
Q2 | $954K | Buy |
6,932
+5,532
| +395% | +$762K | 0.01% | 595 |
|
|
2024
Q1 | $193K | Buy |
1,400
+700
| +100% | +$96.5K | ﹤0.01% | 933 |
|
|
2023
Q4 | $92.2K | Hold |
700
| – | – | ﹤0.01% | 658 |
|
|
2023
Q3 | $78.8K | Hold |
700
| – | – | ﹤0.01% | 639 |
|
|
2023
Q2 | $66K | Buy |
+700
| New | +$66K | ﹤0.01% | 668 |
|